Literature DB >> 22980166

Comparison of the effect of the metabolic syndrome and multiple traditional cardiovascular risk factors on vascular function.

Jing Li1, Andreas J Flammer, Ryan J Lennon, Rebecca E Nelson, Rajiv Gulati, Paul A Friedman, Randal J Thomas, Nicole P Sandhu, Qi Hua, Lilach O Lerman, Amir Lerman.   

Abstract

OBJECTIVE: To assess the effect of the metabolic syndrome (MetS) on endothelial function and compare these findings to those in individuals with a similar burden of traditional cardiovascular (CV) risk factors (≥ 3) without MetS. PATIENTS AND METHODS: Both MetS and multiple CV risk factors were identified from 1103 individuals who underwent the evaluation of endothelial function at the Mayo Clinic, in Rochester, Minnesota, from July 1, 2000, through July 31, 2011. Endothelial function was measured using digital arterial tonometry by assessing reactive hyperemia-induced vasodilation in one arm and adjusting for changes in the contralateral arm (reactive hyperemia index [RHI]).
RESULTS: A total of 316 individuals with MetS and 210 with multiple risk factors were assessed. Endothelial dysfunction was more pronounced in the MetS group compared with the multiple risk factor group (mean ± SD natural logarithmic RHI, 0.61 ± 0.25 and 0.68 ± 0.28, respectively; P=.006). Leukocyte count (7.00 ± 1.89 × 10(9)/L vs 6.41 ± 1.76 × 10(9)/L, respectively; P=.001) and high-sensitivity C-reactive protein level (1.78 ± 1.53 mg/L vs 1.48 ± 1.42 mg/L, respectively; P=.01) were higher in the MetS group compared with the multiple risk factor group. After adjustment for covariates and 6 traditional CV risk factors in a multivariate regression model, MetS had a significant and independent influence on natural logarithmic RHI (β=-.11; P=.01).
CONCLUSION: The current study found that individuals with MetS have a higher degree of endothelial dysfunction and inflammation compared with individuals with multiple CV risk factors and may therefore have an increased CV risk beyond the contributions of multiple traditional risk factors.
Copyright © 2012 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22980166      PMCID: PMC3538392          DOI: 10.1016/j.mayocp.2012.07.004

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  54 in total

Review 1.  Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force.

Authors: 
Journal:  Sleep       Date:  1999-08-01       Impact factor: 5.849

2.  The prevalence of endothelial dysfunction in patients with and without coronary artery disease.

Authors:  Stefan Toggweiler; Andreas Schoenenberger; Nadja Urbanek; Paul Erne
Journal:  Clin Cardiol       Date:  2010-12       Impact factor: 2.882

3.  Which white blood cell subtypes predict increased cardiovascular risk?

Authors:  Benjamin D Horne; Jeffrey L Anderson; Jerry M John; Aaron Weaver; Tami L Bair; Kurt R Jensen; Dale G Renlund; Joseph B Muhlestein
Journal:  J Am Coll Cardiol       Date:  2005-04-25       Impact factor: 24.094

4.  Role of the metabolic syndrome in risk assessment for coronary heart disease.

Authors:  Priya Kohli; Philip Greenland
Journal:  JAMA       Date:  2006-02-15       Impact factor: 56.272

5.  C-reactive protein beyond biomarker of inflammation in metabolic syndrome.

Authors:  Masatsugu Horiuchi; Masaki Mogi
Journal:  Hypertension       Date:  2011-02-28       Impact factor: 10.190

6.  Effect of rosiglitazone on endothelial function and inflammatory markers in patients with the metabolic syndrome.

Authors:  Katherine Esposito; Miryam Ciotola; Diego Carleo; Bruno Schisano; Franco Saccomanno; Ferdinando Carlo Sasso; Domenico Cozzolino; Roberta Assaloni; Domenico Merante; Antonio Ceriello; Dario Giugliano
Journal:  Diabetes Care       Date:  2006-05       Impact factor: 19.112

Review 7.  The metabolic syndrome.

Authors:  Robert H Eckel; Scott M Grundy; Paul Z Zimmet
Journal:  Lancet       Date:  2005 Apr 16-22       Impact factor: 79.321

8.  Obstructive sleep apnea and aging effects on macrovascular and microcirculatory function.

Authors:  Susie Yim-Yeh; Shilpa Rahangdale; Anh Tu Duy Nguyen; Amy S Jordan; Victor Novack; Aristidis Veves; Atul Malhotra
Journal:  Sleep       Date:  2010-09       Impact factor: 5.849

9.  Myeloperoxidase, a leukocyte-derived vascular NO oxidase.

Authors:  Jason P Eiserich; Stephan Baldus; Marie-Luise Brennan; Wenxin Ma; Chunxiang Zhang; Albert Tousson; Laura Castro; Aldons J Lusis; William M Nauseef; C Roger White; Bruce A Freeman
Journal:  Science       Date:  2002-06-28       Impact factor: 47.728

Review 10.  Effects of antidiabetic and antihyperlipidemic agents on C-reactive protein.

Authors:  Paresh Dandona
Journal:  Mayo Clin Proc       Date:  2008-03       Impact factor: 7.616

View more
  14 in total

1.  Heart disease and stroke statistics--2014 update: a report from the American Heart Association.

Authors:  Alan S Go; Dariush Mozaffarian; Véronique L Roger; Emelia J Benjamin; Jarett D Berry; Michael J Blaha; Shifan Dai; Earl S Ford; Caroline S Fox; Sheila Franco; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Mark D Huffman; Suzanne E Judd; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Rachel H Mackey; David J Magid; Gregory M Marcus; Ariane Marelli; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Michael E Mussolino; Robert W Neumar; Graham Nichol; Dilip K Pandey; Nina P Paynter; Matthew J Reeves; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2013-12-18       Impact factor: 29.690

Review 2.  Endothelial dysfunction over the course of coronary artery disease.

Authors:  Enrique Gutiérrez; Andreas J Flammer; Lilach O Lerman; Jaime Elízaga; Amir Lerman; Francisco Fernández-Avilés
Journal:  Eur Heart J       Date:  2013-09-07       Impact factor: 29.983

Review 3.  Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association.

Authors:  Emelia J Benjamin; Michael J Blaha; Stephanie E Chiuve; Mary Cushman; Sandeep R Das; Rajat Deo; Sarah D de Ferranti; James Floyd; Myriam Fornage; Cathleen Gillespie; Carmen R Isasi; Monik C Jiménez; Lori Chaffin Jordan; Suzanne E Judd; Daniel Lackland; Judith H Lichtman; Lynda Lisabeth; Simin Liu; Chris T Longenecker; Rachel H Mackey; Kunihiro Matsushita; Dariush Mozaffarian; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Latha Palaniappan; Dilip K Pandey; Ravi R Thiagarajan; Mathew J Reeves; Matthew Ritchey; Carlos J Rodriguez; Gregory A Roth; Wayne D Rosamond; Comilla Sasson; Amytis Towfighi; Connie W Tsao; Melanie B Turner; Salim S Virani; Jenifer H Voeks; Joshua Z Willey; John T Wilkins; Jason Hy Wu; Heather M Alger; Sally S Wong; Paul Muntner
Journal:  Circulation       Date:  2017-01-25       Impact factor: 29.690

4.  Utility of both carotid intima-media thickness and endothelial function for cardiovascular risk stratification in patients with angina-like symptoms.

Authors:  Yasushi Matsuzawa; Sara Svedlund; Tatsuo Aoki; Raviteja R Guddeti; Taek-Geun Kwon; Rebecca Cilluffo; R Jay Widmer; Rebecca E Nelson; Ryan J Lennon; Lilach O Lerman; Sinsia Gao; Peter Ganz; Li-Ming Gan; Amir Lerman
Journal:  Int J Cardiol       Date:  2015-04-16       Impact factor: 4.164

Review 5.  From inflammation to sexual dysfunctions: a journey through diabetes, obesity, and metabolic syndrome.

Authors:  M I Maiorino; G Bellastella; D Giugliano; K Esposito
Journal:  J Endocrinol Invest       Date:  2018-03-16       Impact factor: 4.256

6.  High leukocyte count is associated with peripheral vascular dysfunction in individuals with low cardiovascular risk.

Authors:  Jing Li; Andreas J Flammer; Martin K Reriani; Yoshiki Matsuo; Rajiv Gulati; Paul A Friedman; Randal J Thomas; Nicole P Sandhu; Lilach O Lerman; Amir Lerman
Journal:  Circ J       Date:  2012-12-06       Impact factor: 2.993

Review 7.  The importance of autophagy in cardioprotection.

Authors:  Sebastiano Sciarretta; Derek Yee; Varun Shenoy; Narayani Nagarajan; Junichi Sadoshima
Journal:  High Blood Press Cardiovasc Prev       Date:  2013-11-14

8.  Postprandial decrease in LDL-cholesterol in men with metabolic syndrome.

Authors:  Anna Skoczyńska; Barbara Turczyn; Anna Wojakowska; Bogusława Kreczyńska; Marta Skoczyńska; Kamila Wojtas
Journal:  Open Med (Wars)       Date:  2015-02-03

9.  The impact of long-term changes in metabolic status on cardiovascular biomarkers and microvascular endothelial function in middle-aged men: a 25-year prospective study.

Authors:  Magdalena Kwaśniewska; Joanna Kozińska; Elżbieta Dziankowska-Zaborszczyk; Tomasz Kostka; Anna Jegier; Ewa Rębowska; Milena Orczykowska; Joanna Leszczyńska; Wojciech Drygas
Journal:  Diabetol Metab Syndr       Date:  2015-09-17       Impact factor: 3.320

10.  Impact of individual metabolic risk components or its clustering on endothelial and smooth muscle cell function in men.

Authors:  Michio Shimabukuro; Namio Higa; Hiroaki Masuzaki; Masataka Sata; Shinichiro Ueda
Journal:  Cardiovasc Diabetol       Date:  2016-05-17       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.